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My ultimate goal in writing this thesis was to become further educated on the topic of mental health  
in order to better understand myself and those around me.  
I dedicate this work to those suffering from mental illnesses of all variations, 
And specifically, to my loved ones who struggle daily with their mental health. 
Individuals must realize the reality of mental illness as just that—an illness. 
Depression is not a choice. 
Anxiety is not a choice. 
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Hypothyroidism is a form of thyroid dysfunction that occurs when the thyroid gland does not make 
and secrete enough thyroid hormones to regulate certain processes in the body. Because thyroid 
hormones take part in many bodily functions, hypothyroidism can cause a large range of symptoms. 
Current research indicates that some strains of probiotics have beneficial effects on certain 
neurological and inflammatory diseases, leading to the impression that they can be used 
therapeutically for effective treatment of different mental health issues such as anxiety, stress, 
depression, and impaired memory. Because hypothyroidism often leads to such mental symptoms, it 
may be possible that probiotic treatments reverse these symptoms in hypothyroid patients. The 
current proposal aims to 1) observe the effects of probiotic strains Bifidobacterium longum, 
Bifidobacterium breve, and Bifidobacterium infantis on hypothyroid patients suffering from minor 
to severe anxiety and depression and 2) observe the effects of the same strains on cognition in 
hypothyroid male Sprague-Dawley rats. It is predicted that probiotics will reduce depressive and 
anxiety symptoms in humans and improve memory and learning in rats. 
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LIST OF ABBREVIATIONS 
 
ASD Autism spectrum disorder 
ANS Autonomic nervous system 
BBB Blood-brain barrier 
BDNF Brain-derived neurotrophic factor 
CNS Central nervous system 
DIT Diiodotyrosine 
ENS Enteric nervous system 
ELISA Enzyme-linked immunosorbent assay 
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LTD Long-term depression 
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NMDA N-methyl-D-aspartate glutamate 
receptor 
PD Panic disorder 
PNS Peripheral nervous system 
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SCFA Short chain fatty acid 
TG Thyroglobulin 
TH Thyroid hormone 
TSH Thyrotropin/Thyroid- stimulating 
hormone 
TRH Thyrotropin-releasing hormone 
T4 Thyroxine 
T3 Triiodothyronine 






 Hypothyroidism is a disorder characterized by the low production of thyroid hormones by 
the thyroid gland, a structure in the body essential for regulation and use of energy (Figure 1).1,2 
Thus, hypothyroidism is associated with 
slower metabolic functions and may 
contribute to poorer quality of life. Five out 
of every one hundred people in the United 
States are impacted by hypothyroidism, with 
the majority of those affected being 
women.3 Hypothyroidism has several 
different causes, with the most common 
cause being autoimmune thyroid disease.2 
The thyroid gland and thyroid hormones 
affect many different biological processes, leading to a wide range of symptoms when 
dysfunction occurs. Commonly associated with hypothyroidism are symptoms of depression, 
anxiety, and neurocognitive impairment, which may not be reversed with thyroid hormone 
replacement therapy.4 Notably, psychiatric symptoms often present earliest and most 
conspicuously in hypothyroid patients.5 Consequently, hypothyroidism may first be 
misdiagnosed as psychiatric disturbance.5       
 Patients with hypothyroidism may go years without proper diagnosis or treatment. Since 
symptoms are so nonspecific, and may be attributed to other health issues, it can be difficult to 
identify hypothyroidism as the primary cause. Approximately 13 million people in the United 
States are currently living with undiagnosed hypothyroidism.2 Misdiagnosis and persistence of 
 
Figure 1. Hypothyroidism is characterized by 
low serum T3 and T4 thyroid hormone, which 
may lead to elevated serum levels of thyroid 
stimulating hormone (TSH).2 
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symptoms despite treatment attempts contribute greatly to the frustration of being unable to 
improve quality of living. Patients suffering from undiagnosed hypothyroidism may experience 
fatigue, weight gain, or chronic pain, with no certainty of the cause. Proper diagnosis of 
hypothyroidism is a crucial first step in patients attaining a higher quality of life. The next crucial 
step is to determine the most effective way to treat symptoms that still persist even after normal 
thyroid hormone levels are reached. Some symptoms such as weight gain and fatigue have been 
reported to remain despite treatment.2 However, the treatment of persistent symptoms of anxiety, 




The Thyroid and its Functions 
The thyroid gland is a hormone secreting structure in the endocrine system, most easily 
identified by its butterfly-like shape (Figure 2).6 Two 
ovaloid lobes lie on either side of the trachea, joined by an 
isthmus which crosses the trachea ventrally.7 Groups of 
spherical follicles filled with fluid make up the lobes of the 
gland.7 Follicles are formed by a single layer of follicular 
epithelial cells, also known as thyrocytes, which contain 
tight junctions that form a strong barrier and prevent 
diffusion of transmembrane proteins through the apical and 
basolateral sections of the plasma membrane.8  
Follicular cells along the walls of the thyroid gland use iodine to produce a glycoprotein 
called thyroglobulin (TG), which is necessary for the production of thyroid hormone (TH).6 
Absorption of iodide occurs in the gastrointestinal tract, where it travels through the bloodstream 
to the basolateral plasma membranes of follicular cells.8 Iodide is converted to iodine by 
oxidation in the follicular lumen, where it then binds to the tyrosine residues.8 Iodine atoms 
within the body attach to tyrosyl residues of TG, producing colloid, which is stored in the central 
cavities of follicles and used to produce thyroid hormone.6 Monoiodotyrosine (MIT) and 
diiodotyrosine (DIT) are produced, containing one or two iodines respectively.6 MIT and DIT 
are then coupled to form the two types of thyroid hormone, which are both made up of iodine 
atoms and two tyrosine amino acids.6 Thyroxine (T4) contains four iodine atoms, while 
triiodothyronine (T3) contains three. TH is produced through receptor binding of thyrotropin, or 




thyroid- stimulating hormone (TSH), onto follicular cells and may be produced in large amounts 
outside of the cell.6 T4 is the major hormone produced by the thyroid gland. However, T3 is more 
active in the body.9 T3 has a major role in signaling the negative feedback loop of the 
hypothalamus-pituitary-thyroid (HPT) axis (Figure 3). The HPT axis regulates the concentration 
of T3 and T4 in the body. Thyrotropin-releasing hormone (TRH) in the hypothalamus region of 
the brain has important roles in energy metabolism, feeding behavior, heat production, and 
regulation of certain autonomic nervous system processes.9 In addition, release of TRH from the 
hypothalamus stimulates TSH synthesis and release. TSH is an important hormone in the 
pituitary gland that regulates iodine uptake by thyroid cells, contributes to thyroid cell 
differentiation and growth, and stimulates TH production and release by the thyroid gland.9 
Overall, concentration levels of T3 in the body negatively regulate how much or how frequently 
TRH is released from the hypothalamus, and therefore how much TSH is released from the 
pituitary gland .9 When TH levels are high, a signal is sent to the hypothalamus to reduce release 
of TRH, which results in lower production of 
hormones. Likewise, if TH levels 
are too low, TRH release will 
increase in order for more 
hormones to be synthesized by the 
thyroid.3,9 Although less is known 
about the mechanism involved, THs 
may also directly inhibit release of 
TSH from vesicles in the pituitary 
                                     
 
Figure 3. The HPT axis uses negative 




gland, which also results in lower production of hormones.9  
 Both T3 and T4 are made and secreted by the thyroid, but 80% of serum T3 is converted 
from T4 through the removal of an iodine by a deiodinase. There are three types of deiodinases 
(D1-D3), which differ in preferred substrates, tissue location, physiological function, and 
response to excess T4 (Table 1).
9 Importantly, D1 is the only deiodinase inhibited by 
administration of propylthiouracil (PTU), a compound used to induce hypothyroidism in animal 
models, or to treat hyperthyroidism. Inhibition of D1 causes decreased conversion of T4 to T3, 





Table 1. Deiodinases (D1-D3) differ in which substrates they bind to, which 





The vast majority of THs bind to blood plasma proteins once released by the thyroid.9 
Upon entering a cell’s nucleus, TH binds to receptors, which then initiate transcription of mRNA 
and lead to protein synthesis (Figure 4).6 Since TH reacts with most cells within the body, the 
thyroid gland affects numerous biological processes.6 Proteins synthesized through this process 
affect the nervous, cardiovascular, muscular, skeletal, gastrointestinal (GI), reproductive, and 
integumentary systems, as well as basal metabolic rate and macromolecule (carbohydrate, lipid, 
protein) metabolism.6  






Figure 4. T4 enters the cell where it is converted to T3. It then binds to 




Normal TH levels are essential for proper brain development and function. THs play a 
role in myelination of axons, cell migration, and differentiation of neurons. They also regulate 
the expression of several genes involved in synaptic plasticity and memory, such as CAMKII 
and neuroganin.9 It has been shown that inadequate TH levels leads to a decrease in neurogenesis 
of the hippocampus, a brain region highly involved in cognition, and more specifically in 
learning and memory.11 Effects of insufficient TH levels are much more severe when present 
during child development.11 The severity of these effects emphasizes the importance of THs for 
normal brain development and function.  
THs are essential for normal development of the retina, tectorial membrane, hair cells, 
and middle ear ossicles. Furthermore, T3 is necessary for the processing of sound information. 
Thus, altered TH levels, specifically during development, may prevent proper sensory functions.9 
THs also affect heart development and function. T3 controls gene expression of several genes 
involved in cardiomyocyte, heart cell, growth and function. High T3 levels may lead to excessive 
stimulus of the heart, causing cardiac hypertrophy, which is enlargement of the heart. Low T3 
levels may lead to slowed heart rate, known as bradycardia, which can cause dizziness and 
weakness.9 Furthermore, THs play important roles in bone development, linear growth, and 
maturation, as well as regulation of bone reabsorption which promotes skeletal strength.9  
Finally, THs are essential for the regulation of energy and nutrient metabolism. They 
control energy utilization and thermogenesis.9 Body temperature is maintained through 
obligatory and facultative methods, which are both stimulated by THs. Obligatory thermogenesis 
involves the constant maintenance of standard body temperature (37°C), while facultative 
thermogenesis involves the induction of shivering reflexes when the body is exposed to cold 
temperatures.9 Low TH production causes cold intolerance and may lead to development of 
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hypothermia in extreme cases, while high TH production causes heat intolerance.9 THs regulate 
the degradation and synthesis of lipids, and high levels of TH increase lipolysis. In addition, THs 
increase synthesis and oxidation of fatty acids in the liver, as well as their conversion to 
triglycerides, and stimulate synthesis of cholesterol and its uptake. Low TH levels lead to 
reduced metabolic function, while high levels lead to excessive metabolism. THs regulate protein 
synthesis and degradation, with high TH levels leading to increased degradation and loss of 
protein in muscles. THs also effect metabolism of carbohydrates and have recently been found to 
stimulate appetite. Evidently, the thyroid is crucial for normal development and metabolic 
function. Consequently, its dysfunction can lead to malfunctions within any of the mentioned 
systems and processes.  
Thyroid Dysfunction: Hyper- and Hypothyroidism 
Thyroid dysfunction may arise in several ways (Figure 5). One such way is 
hyperthyroidism, a condition characterized by the high production and secretion of thyroid 
hormones.12 The most common cause of hyperthyroidism is an autoimmune disorder called 
Grave’s disease. This disease involves the production of antibodies which bind to TSH receptors 
and stimulate the synthesis of THs. Thus, Grave’s disease is characterized by low levels of serum 
TSH due to negative feedback by high amounts of serum TH.12,13 
Hyperthyroidism has a prevalence of 1.2% in the United States.13 Symptoms are broad 
and nonspecific, making the disease difficult to diagnose. However, testing serum TSH levels is 
usually an effective way to correctly diagnose the disease13 Patients with hyperthyroidism may 
have increased heat production and intolerance to heat, low serum cholesterol levels, protein loss 
in muscles and various tissues (leading to weight loss), increased appetite, decreased bone 
integrity and linear growth, and increased heart rate, which may lead to heart failure.9,14 
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Hyperthyroid patients may also present neurological symptoms such as anxiety, rapid speech, 
sleep disturbance, and psychosis.13 Persistence of both physical and mental symptoms can be 
detrimental to the health of these patients.  
There are few treatment options for hyperthyroidism. Antithyroid medications that inhibit 
TH production, such as methimazole or PTU, may be used as initial treatment for 
hyperthyroidism. However, the risk of adverse effects may increase with their long-term use.13 
Another treatment option is ablation of the thyroid gland through uptake of radioactive iodine. 
Once the thyroid gland is “killed”, hypothyroidism will most likely develop after several months.   
The final treatment option involves surgical removal of the thyroid, known as thyroidectomy. 
Similar to radioactive iodine ablation, hypothyroidism will generally develop after several 




Figure 5. Hyperthyroidism is characterized by low TSH and high TH. Primary 
hypothyroidism is characterized by high TSH due to lack of TH.87  
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Hypothyroidism is a form of thyroid dysfunction involving low production and secretion 
of thyroid hormones. Normal thyroid function involves interaction with the hypothalamus, a 
region of the brain.3 The hypothalamus determines when TH levels are too low or high. In 
response to TH imbalance, a signal is sent to the pituitary gland, which sends TSH to the 
receptors on follicular cells involved in TH synthesis and release.3 In hypothyroidism, the 
thyroid gland is lacking in its ability to respond to TSH. Thus, thyroid hormone is not produced 
efficiently in underactive thyroids.3 Because the thyroid gland plays a large role in regulating the 
body’s use of energy, many biological processes slow down with lack of thyroid hormone.3  
There are several causes of hypothyroidism, with the most common cause being an 
inflammatory disorder called Hashimoto’s disease.3 Like Grave’s disease, Hashimoto’s is an 
autoimmune disorder that depends on both genetic and environmental factors.16 The disease 
leads to the gradual atrophy, or wasting away, of the thyroid gland after being invaded by 
lymphocytic cells of the immune system. Other than the fact that lymphocytes are involved, the 
pathogenesis of Hashimoto’s is not fully understood.16 
Congenital hypothyroidism is a serious disorder that occurs in 
infants born with a malfunctioning or underdeveloped thyroid. 
Symptoms include low energy, increased sleep, difficulty with 
feeding, constipation, and jaundice. Physical deformities may 
be present as well (Figure 6).17 Congenital hypothyroidism 
may be permanent, demanding treatment throughout life, or 
transient, waning after several months. Risk of permanent 
congenital hypothyroidism is more likely to occur in iodine-
    
 
 
    










deficient countries.17 Permanent congenital hypothyroidism is  frequently accompanied by 
mental retardation, impaired cognition, and sometimes hearing loss.9  
One cause of a temporary form of hypothyroidism is thyroiditis. Thyroiditis is 
inflammation of the thyroid that first causes hyperthyroidism by leaking thyroid hormones. After 
several months, the thyroid may enter into hypothyroidism before returning to normal.3  As 
mentioned before, treatment options for hyperthyroidism generally lead to the development of 
hypothyroidism. Thus, hypothyroidism may occur through whole or partial removal of the 
thyroid gland when needed to treat hyperthyroidism or thyroid cancer.      
Like hyperthyroidism, patients with hypothyroidism have a wide range of symptoms 
including poor mental health, cognitive impairment, sexual dysfunction, decreased 
macromolecule metabolism, lowered basal metabolic rate, weight gain, joint pain, slowed 
reflexes and muscle actions, and irregular heart rates.4,6,18,19  Persistence of symptoms may 
contribute to more serious health issues such as hypertension, abnormal lipid levels, infertility, or 
neuromuscular dysfunction.2  
Mental health issues such as anxiety, stress, and depression are some of the most 
common yet most overlooked health issues in the medical realm. Depression alone may cause 
cognitive impairments, emotional imbalance, memory deficiencies, lack of motivation, limited 
motor function, and dissociation from society.20 Depressive symptoms often precede 
hypothyroidism, and in other cases hypothyroidism may increase the likeliness for depressive 
disorders to develop.21 Feelings of sadness, hopelessness, worthlessness, emptiness, anxiety, and 
restlessness are characteristic of depressive disorders. People suffering from depression often 
lose interest in activities previously enjoyed, avoid social interaction, have abnormal eating and 
sleeping habits, have trouble concentrating, and in some cases, experience suicidal thoughts or 
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attempt suicide.22 There are also generally other chronic illnesses associated with depression, 
such as irritable bowel syndrome (IBS). The costs of therapy, antidepressants, reduced 
motivation in the workplace, and additional treatment of secondary illnesses make depression a 
very large financial medical burden.20  
Hypothyroid patients may also present symptoms that are also characteristic of 
generalized anxiety disorders (GADs), such as anxiety, sleep difficulty, fatigue, and attention 
deficits.21  Additionally, hypothyroid patients may display symptoms that also occur in patients 
with panic disorders (PDs) during panic attacks, such as heart palpitations, irregular breathing, 
and increased sweating.21 Similar to depressive disorders, anxiety disorders often precede the 
development of thyroid dysfunction. However, patients with thyroid dysfunction are more likely 
to develop anxiety disorders.21 Overall, symptoms of anxiety and depressive disorders may 
overlap with those of hypothyroidism, making it difficult to determine which is contributing to 
the presence of those symptoms and what type of treatment should be used.   
Hypothyroidism also impairs synaptic plasticity and cognition, specifically learning and 
memory.11,23 Synaptic plasticity is the ability for neuronal synapses to strengthen or weaken in 
order to mediate efficient storage of information in the hippocampus, both short-term and long-
term.24 The two types of long-term synaptic plasticity are long-term potentiation (LTP) and long-
term depression (LTD). LTP is the strengthening of synapses, while LTD is the weakening.24 
Increased LTP is associated with enhanced learning and memory, while increased LTD (or 
decreased LTP) is associated with impaired learning and memory processes.23 Hypothyroidism 




Symptoms vary greatly between hypothyroid patients, and some may be subtle or not 
present at all.2 Once diagnosed, the primary treatment for hypothyroidism is thyroid hormone 
replacement therapy through administration of levothyroxine (LT4), a synthetic form of T4.
25 
This synthetic form of T4 is then converted to serum T3. Thus, levothyroxine treatment alleviates 
symptoms of hypothyroid patients by normalizing serum T4 and T3, and consequently TSH.
25,26 
However, it has been reported that attaining normal thyroid hormone levels, called euthyroidism, 
does not guarantee a reversal of all symptoms associated with hypothyroidism.25 While 
antidepressant and anxiolytic treatments are generally effective for depressive and anxiety 
symptoms, long-term use of these medications may increase the risk of unwanted effects and 
health complications in patients.27,28 Neurocognitive impairments, specifically in memory and 
attention, have also been reported to persist in hypothyroid patients despite adequate, long-term 
levothyroxine treatment.26 Interestingly, symptoms of depression, anxiety, and neurocognitive 






The Gut-Brain Axis 
It has long been understood that brain function is connected to the microbiome in the GI 
tract. The GI tract is extremely complex, spanning five meters, containing the majority of 
immune cells within the body, as well as hundreds of millions of neurons. More so, the 
microbiome of the GI tract contains trillions of cells and hundreds of varying species.35 The 
brain-gut axis is a bidirectional communication system that involves the central nervous system 
(CNS) and enteric nervous system (ENS).36 The ENS is a branch of the peripheral nervous 
system (PNS), as is the autonomic nervous system (ANS), which is responsible for involuntary 
bodily responses.35 The ANS may be further divided into sympathetic and parasympathetic. 
Nerves within these systems may send signals and synapse directly onto the GI tract. The vagus 
nerve, an important parasympathetic nerve, connects the hindbrain, esophagus, and GI tract.35 
Stimulation of the vagus nerve can produce anti-inflammatory responses, providing evidence of 
its role in gut-brain communication.37 The CNS encompasses the spinal cord and brain, and the 
ENS encompasses the gastrointestinal system, regulating its functions through neuronal 
receptors.35 Connections between microbiota of the GI tract and the brain have been shown to 
have roles in gastrointestinal disorders, obesity, anxiety, stress, depression, cognition, and 
possibly even autism.36,38,39  
Importance of the Gut Microbiome 
Gut microbiota have a mutualistic relationship with their hosts. Their presence is 
imperative for immune responses, fat distribution, absorption of nutrients, and gut contractions, 
and gut integrity.40 Alterations of the gut microbiome early on in life may have detrimental 
effects on health. For example, when infants are delivered vaginally, they acquire microbes from 
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the existing microbiome of the mother. However, when delivered by cesarean section, infants 
may not acquire a wide variety of microbial populations.41 Prenatal stress may also influence the 
population of microbes in an infant’s microbiome. An altered gut microbiome at birth has been 
shown to increase risk of infants manifesting an autoimmune disease later in life.41 Antibiotic use 
early in life may also alter the microbiome, impacting development, metabolism, immune health, 
and behavior.41 Germ-free rodent models with sterilized gut microbiomes are frequently used for 
microbiome studies. These models tend to display significant impairments in behavior, 
cognition, and neurochemistry (Figure 7).39 Fecal transplant studies are done to observe the 
effects of different microbial populations on behavior and physiology. Infection studies are also 
done to observe the effects of pathogens on behavior and physiology (Figure 8).40 
 
           
 
Figure 7. Phenotypes exhibited by germ-free mice. Decreased memory, sociability, 
anxiety, and BDNF. Increased locomotion, self-grooming, serotonin, 




One current research topic of interest is the possible role of the gut microbiome in 
connection with autism spectrum disorder (ASD). According to recent studies, children with 
ASD tend to exhibit an increased number of Clostridia species in their microbiomes. 41,42 
Interestingly, the gut microbiome has also been elucidated to have a possible role in other 
diseases such as schizophrenia, Parkinson’s disease, and Alzheimer’s disease.41 The occurrence 
of altered microbiomes in these diseases only enhances the excitement of the idea that gut 
microbes may be involved in other diseases that have not yet been observed. In adulthood, the 
microbiome is more diverse and less susceptible to change. However, factors such as change in 
diet, geography, and lifestyle may alter the adult gut microbiome, which may lead to changes in 
health.41 
 
Figure 8. The microbiota-gut-brain axis is studied through a variety of methods.40  
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Probiotics   
The term “psychobiotics” encompasses any substance that affects the bacteria-brain 
relationship, which includes probiotics, prebiotics, antibiotics, and antipsychotic drugs.37 
Psychobiotics influence the body physically and psychologically due to the existence of the 
brain-gut axis.37 Generally speaking, probiotics are bacteria that produce beneficial effects on 
health when administered in adequate quantities, an amount which varies between 
individuals.36,38  
Probiotic Strains Used Experimentally 
There have been several studies, mostly preclinical, on the effects of probiotics on mood, 
stress, cognition, anxiety, and inflammation. Strains administered to test effects on mood are 
typically from the genera Lactobacillus or Bifidobacterium. Species used include B. infantis, B. 
longum, L. rhamnosus, and L. helveticus.36,38,43,44 Medicinal antidepressant treatments for 
depression are generally effective, although consistent use increases the risk for adverse effects.27 
In addition, current antidepressant medications are limited, and only treat specific aspects of the 
depression, such as reduced levels of serotonin.20  
A multi-species microbial “cocktail” is being proposed for treatment due to the fact that 
different probiotic species produce different beneficial chemicals. Lactobacillus and 
Bifidobacterium species produce gamma-aminobutyric acid (GABA), an inhibitory 
neurotransmitter. Candida, Streptococcus, Escherichia, and Enterococcus species produce 
serotonin, a neurotransmitter involved in mood regulation. Bacillus species produce dopamine, a 
neurotransmitter involved in processes such as reward, motivation, and memory. 
Bifidobacterium infantis in particular has been shown to alter kynurenine concentrations in the 
body, thus altering inflammation.40 Lactobacillus and Bifidobacterium are also known to produce 
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certain unsaturated fatty acids and short chain fatty acids (SCFAs) that support cognitive 
function, brain development, and reduce inflammation.27 For this proposal, species only from 
genera Bifidobacteria will be used in order to limit inhibition that can arise from having differing 
strains. Lactobacilli has been shown to inhibit other probiotic species on a larger scale than 
Bifidobacteria.45                                                                                           
Genera Bifidobacteria 
 The Bifidobacterium genus contains over 50 different species, with new species emerging 
each year.46 Generally speaking, members of Bifidobacterium contribute to metabolic function 
by breaking down monosaccharides.46 These bacteria are found in small portions in the human 
gut microbiome, among many other microbial populations. However, they are found in larger 
quantities within the microbiomes of infants, most likely due to the presence of oligosaccharides 
in breast milk.46 Studies show that Bifidobacteria contribute to defense against pathogens and 
reduce risk of infection through various mechanisms, including synthesis of organic acids and 
antibacterial peptides. Specifically, Bifidobacteria has been observed to reduce the presence of 
Helicobacter pylori, thus reducing risk of infection.46 Notably, members of Bifidobacteria may 








PROBIOTIC ADMINISTRATION AS TREATMENT  
FOR HYPOTHYROID SYMPTOMS 
Biochemical interactions and pathways involved in emotion and cognition 
Psychophysiological effects of microbiota on the brain include modulation of 
inflammatory and stress processes, changes in emotional and cognitive responses, and 
production or reduction of neurotransmitters and proteins. Pathogens cause the immune system 
to release toxins and inflammatory cytokines into the body, which then cause adverse 
neurochemical changes. Probiotics have the ability to exclude pathogens through inhibition, 
interfere with signal transduction pathways, and produce antagonists which bind to inflammatory 
cytokines and prevent normal inflammatory responses.27,48 Inflammation in the CNS is 
associated with negative psychological health, including depression, anxiety, and stress.  
Probiotics also have roles in lipid metabolism and maintaining tight junctions to prevent 
permeability in the blood-brain barrier (BBB).  The gut-microbiome-brain (GMB) connection, 
which is the idea of complex interconnectedness and biochemical communication between such 
parts of the body, is important in understanding how probiotics affect mood.27 
The tryptophan kynurenine pathway is a mechanism also involved in the brain-gut axis. 
Tryptophan is an amino acid that is a precursor for serotonin production. Probiotics produce 
several neural substances that are helpful in improving behavior. Thus, their role as therapy for 
neural disorders is promising.49  Manipulation of tryptophan, and consequently serotonin levels, 
affect mood and cognition, which includes learning and memory. In general, lower serotonin 
levels in the brain correlate with worse memory and more depressed mood.50 One study showed 
that depletion of tryptophan in non-depressed individuals had little effect on mood, while in 
depressed individuals, mood worsened. Similar results were observed in studies done in rats. 
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Additionally, it was suggested that tryptophan increases sleepiness, thus improving quality of 
sleep in depressed individuals who tend to suffer from lack of good sleep.50 Certain microbiota, 
such as lactic acid bacteria, are able to metabolize tryptophan. Overall, increased consumption of 
foods that contain tryptophan will increase serotonin levels and improve mood in depressed 
individuals.50 In addition, probiotics can help regulate the hypothalamic-pituitary-adrenal (HPA) 
axis, thereby reducing stress which is a factor of both anxiety and depression.51 
The gastrointestinal microbiota also influence the presence of brain-derived neurotrophic 
factor (BDNF), which is a neurotrophic protein. Gut bacteria may control how BDNF functions 
in the CNS by causing changes in function of neurotransmitters and SCFAs.49 Abnormal levels 
of hippocampal BDNF have been connected with weakening of synaptic transmissions and 
plasticity, thus resulting in cognitive impairments.49 BDNF signaling occurs through the binding 
of two isoforms (m-BDNF and pro-BDNF) to two different neuronal membrane-bound receptors 
known as tyrosine kinase receptor (TrkB) and p75.52,53 m-BDNF binding to TrkB is associated 
with LTP, while pro-BDNF binding to p75 is associated with LTD.52,54 m-BDNF aids in 
development of neurons and glial cells, sustains strength of synapses, and decreases excitability 
of inhibitory GABA interneurons, functions that all contribute to LTP and memory 
persistence.54–56 BDNF appears to be closely linked with the presence of N-methyl-D-aspartate 
(NMDA) glutamate receptors.49 NMDA receptors are present on pre- and post-synaptic sites on 
neurons. They are involved in forming, controlling, and strengthening synaptic communications 
and modifying neurons.49,55 BDNF modulation affects the function of NMDA receptors. 
Specifically, BDNF interacts with NMDA receptors to increase excitatory synaptic transmission 
of neurons. Furthermore, NMDA receptors support synthesis of BDNF.49,57 Overall, deficits in 
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BDNF may lead to dysfunction of NMDA glutamate receptors, which is associated with 
depression and cognitive impairments.49 
Hypothyroidism in rats has been shown to cause variations in BDNF, death of neurons 
and astrocytes, gliosis, and worsening of postsynaptic density.58 Astrocytes are important in 
maintaining balance of ionic K+ in the extracellular space, as well as in recycling glutamate and 
GABA. These roles are crucial in plasticity and the transmission of synapses.59,60 In addition, 
astrocytes express many receptors that could be involved in memory and learning, including 
AMPA, NMDA, GABA, BDNF, serotonin, and IL-1β.59 In one study, human glial progenitor 
cells were engrafted into the brains of neonatal immunodeficient mice. As the mice developed, 
they gained large amounts of human glial progenitors and astrocytes. It was shown that LTP and 
learning were increased compared to controls.59,61 Thus, analysis of astrocytes may be important 
in recognizing cognitive deficits in humans and rodent models of hypothyroidism. 
Animal Models Used Experimentally 
Rodents are commonly used in probiotic preclinical trials and experiments, including 
models of Sprague-Dawley rats, Wistar rats, and neonatal or adult mice. Due to genetic 
differences in different strains and species of rodents, probiotics of the same species often have 
different effects depending on the rodent model used. There are some cases where beneficial 
probiotic effects are observed in one study, but no effects are observed in a subsequent study.62  
A variety of tests exist to measure certain behaviors in rodents. The open field test 
examines anxious behaviors by measuring how long the rodent spends time away from a marked, 
center space. The forced swim test (FST) is used to measure depressive behaviors by observing 
how much rodents struggle to swim around in an enclosed pool of water.37,63 Swimming, 
climbing, and immobility may be observed, and longer periods of immobility generally indicate 
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depressive behavior.64 Maze-learning tasks, such as the Barnes maze and Morris water maze, are 
generally used to examine changes in memory, spatial learning, and anxious behaviors (Figure 
9).37 Fear conditioning and object recognition tests are used to test nonspatial learning and 
memory (Figure 10).37  
 
  
Figure 9. Barnes maze.88,89 
Figure 10. Object recognition test.90 
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Relevant Literature: Preclinical and Clinical Probiotic Studies 
Bravo et al. 2011 conducted a preclinical study to observe the effects of Lactobacillus 
rhamnosus administration on neurotransmitter receptors in the CNS, paying special attention to 
GABA receptors.65 The probiotic impacts different regions of the brain, causing an increase of 
GABA in cortical regions and a decrease in the amygdala and hippocampus. Overall, the 
probiotic reduced stress and anxiety-like behaviors in mice.65 Effects in vagatomized mice, 
where the vagus nerve was inhibited, were not present. This aspect of the experiment emphasizes 
the vagus nerve’s role in gut-brain communication.65 
A preclinical study done by Desbonnet et al. 2008 investigated the effects of 
administration of the probiotic Bifidobacteria infantis on normal rats over a 14-day period. 
Effects were measured by observing behavior of rats in a FST, as well as by examining levels of 
cytokines, tryptophan, kynurenic acid, brain monoamines (dopamine, noradrenaline, and 
serotonin), AVP mRNA, CRF mRNA, and corticosterone.66 There was no significant difference 
found between behaviors of control subjects versus probiotic subjects during the FST. This result 
could be due to the lack of stress in the subjects. It was found that Bifidobacteria subjects 
suppressed the release of proinflammatory cytokines compared to controls. Tryptophan and 
kynurenic acid concentrations were increased in probiotic specimens. There were no significant 
effects found in other factors measured.66 The study suggests that Bifidobacteria’s beneficial 
neurological effects only become present in models suffering from severe stress or other 
psychopathological diseases, a phenomenon known as the ceiling effect.37,66 The authors 
conducted a follow-up study using the maternal separation model of depression.66 
In a follow-up study, Desbonnet et al. 2010 investigated the effects of administration of 
the probiotic Bifidobacteria infantis on rats that had suffered early chronic stress through the 
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maternal separation model. The maternal separation (MS) model involves separation of infant 
rats from their mother(s), causing early stress that disrupts the brain and gut.64 The rats were 
separated into the following groups: normal (not separated), MS, MS/probiotic, 
MS/antidepressant (citalopram). Starting at 50 days of age, through day 95, the rats were given 
their assigned treatments. Effects were measured in the same way as the previous study. In the 
FST, the probiotic and antidepressant reduced immobility in rats and increased swim time. There 
was no effect on tryptophan or kynurenic acid in any of the groups. Abnormalities caused by 
maternal separation were found to be normalized in the probiotic and antidepressant groups.64 
The authors state that it is a possibility that MS causes biological alterations which inhibit 
tryptophan production by B. infantis. The results showed how stress can alter the microbiome 
and brain function, as compared to the previous study in normal rats. It is also apparent that B. 
infantis have similar effects to antidepressants, demonstrated by observations in the FST.64 
 A study done by Cortés et al. 2012 observed various biomarkers in hypothyroid adult 
male Sprague-Dawley rats.58 Hypothyroidism was induced by treatment with 6-propyl-2-
thiouracil (PTU) for 20 days. Adult rats with hypothyroidism have displayed reduced neurons in 
the hippocampal brain region, as well as abnormal expression of mRNA that encodes for specific 
subunits of NMDA receptors and TrkBs.58 This study also observed reduced thickness of post 
synaptic density in the brains of hypothyroid rats, higher BDNF levels in their telencephalon 
regions, higher levels of BDNF mRNA in the hippocampal regions, and increased astrocyte 
death. This study provided evidence that hypothyroidism may be damaging to the hippocampal 
region of the brain.58 
 Davari et al. 2013 used probiotics to treat cognitive and synaptic impairment in diabetic-
induced rats.67 Oxidative stress is a primary mechanism that contributes to diabetic symptoms. 
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Thus, damage by oxidative stress is also a contributor to cognitive dysfunction in the disease.67 
Rats were administered a probiotic mixture of Lactobacillus acidophilus, Bifidobacterium lactis, 
and Lactobacillus fermentum dissolved in drinking water for two months. Spatial learning was 
assessed using the Morris water maze and excitatory postsynaptic potentials were measured 
using electrophysiological recordings. Overall, it was shown that probiotic administration 
improved spatial learning and synaptic plasticity in diabetic rats.67 Notably, oxidative stress may 
also be involved in damaging brain tissue and contributing to cognitive impairment in  
hypothyroidism.68  
In a controlled, randomized clinical trial conducted by Steenbergen et al. 2015, the effects 
of probiotics on cognitive reactivity were tested. Cognitive reactivity is triggered when mood 
changes occur, causing irregular thoughts such as those of hopelessness and aggression.69 The 
objective of the experiment was to determine if the administering of probiotics reduces cognitive 
reactivity in healthy, young adults who have not been diagnosed with a mood disorder. 40 
individuals were tested, with 20 in the experimental group and 20 in the placebo group. A triple-
blind design was used, meaning the administer, participants, and assessor did not know which 
samples the placebos were. The probiotic sample contained seven different gut bacteria species: 
B. bifidum, B. lactis, L. acidophilus, L. brevis, L. casei, L. salivarius, and L. lactis. The Leiden 
Index of Depression Sensitivity was used to measure changes in participants’ moods over a four-
week period. The objective was accomplished by showing that overall cognitive reactivity was 
reduced through the ingestion of probiotics.69 However, there were limitations which included an 
unequal ratio of female to male participants, unmonitored diets of participants, and self-
administration of the samples. Regardless, the general effect of probiotics on mood in the 
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experimental group supports the idea that probiotics may be effective in treating mood 
disorders.69 
Furthermore, Aizawa et al. 2016 investigated the bacteria count of Bifidobacterium and 
Lactobacillus in patients with Major Depressive Disorder (MDD) compared to healthy 
controls.44 The results showed a significantly lower amount of Bifidobacterium in subjects with 
MDD. The amount of Lactobacillus in MDD patients was lower, but not as significant as with 
Bifidobacterium. It was also found that IBS was more common in patients with MDD. The study 
also noted that consumption of fermented milk correlated with higher levels of Bifidobacterium 
in subjects.44 Depression was measured using the Hamilton depression rating scale. IBS was 
measured using the ROME III criteria. Fecal samples were used to measure the number of 
bacteria in the gut. A similar number of patients versus healthy subjects were used.44 There were 
limitations in that that gender and diet were not completely taken into account. However, the 
results showed no significant differences due to these limitations. The study offers support for 
the helpful nature of specific probiotics in treating depression.44 
In a clinical trial, Romijn et al. 2017 studied the effects of Lactobacillus helveticus and 
Bifidobacterium longum on individuals suffering from severe MDD symptoms.70 79 randomly 
selected individuals participated, with 40 being in the probiotic group and 39 being in the 
placebo group. Probiotics were administered for 8 weeks, and a variety of baseline tests were 
done. BDNF, IBS symptoms, vitamin D, and levels of proinflammatory cytokines were also 
measured due to their connectedness with depression. The results showed no evidence for 
significant improvement in mood or moderation of inflammation levels after administration of 
the specific probiotic mixture.70 It is suggested that differences in results from other probiotic 
studies could be due to sample size, length of the trial, the severity or treatment resistance of 
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participants, or the bacterial strains used. Another explanation is that the specific probiotics used 
are only effective on low mood individuals, rather than MDD individuals. It is important to note 
that this particular study should not be generalized to all probiotic usage.70 
Because of the success in many studies involving probiotics as treatment for various 




Observing the therapeutic effects of probiotics on impaired memory in hypothyroidism 
The following probiotic experiment is adapted from studies done by Davari et al., 
Savignac et al., and Cortés et al.58,71,72 
Experimental Procedure: 
An animal model for hypothyroidism will be created using adult (7-8 weeks old), male 
Sprague-Dawley rats. To induce hypothyroidism, specimens will be treated with 0.05% of 6-
propyl-2-thiouracil (PTU) in drinking water for a total of 20 days.58 The control group will 
contain 10 rats with no sort of treatment. A second 
group will contain 10 rats treated with PTU. A third 
group will contain 10 rats administered only 
probiotics and no PTU. A fourth group will contain 
10 rats administered both probiotics and PTU (Table 
2). To measure levels of T3, T4, and TSH, serum 
levels of both hypothyroid (PTU) and control rats will 
be analyzed.58 Chemioluminescence will be used to measure serum levels of T3 and T4, while 
radioimmunoassay will be used to measure TSH.58   
The probiotic mixture will contain the strains Bifidobacterium longum, Bifidobacterium breve, 
and Bifidobacterium infantis at a quantity of 1x109 CFU/g. 1 g of the freeze-dried mixture will 
be dissolved in drinking water of each mouse once every 12 hours.71,72 Drinking water intake 
will be measured in all groups to ensure equal consumption. Rats will be fed for 11 weeks total 
before sacrifice and behavioral testing will begin at 3 weeks.72   
 
 
Table 2. Experimental groups. 
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The following behavioral tests will be done to measure memory and learning (Table 3): 






The Barnes Maze is a test for spatial memory. It involves an elevated 
circular platform with 18 holes evenly spaced along the 
circumference. Visual cues are placed around the room to help guide 
the rat to an escape hole. A bright light is placed above the platform, 
which drives a rat’s natural tendency to avoid bright lights and find an 
escape.73  Preliminary training will be done on day 1 by guiding each 
rat using a treat, and testing will be done 15 minutes after training and 








Object recognition, also known as the novel object test, evaluates non-
spatial learning and memory.72,74,75 It demonstrates function of the 
dorsal hippocampus and is based on a rat’s tendency to explore novel 
objects.74,76 The protocol involves three phases. The habituation phase 
allows rats to explore an open arena in the absence of any objects. The 
familiarization phase allows them to explore two identical novel 
objects in the arena. The testing phase replaces one of the objects with 
a different one and observes the rat’s tendency to explore novel 
objects over familiar ones. In this experiment testing will be held in 
week 8 of testing. Each phase will last 10 minutes. The habituation 
phase will occur on the first day, the familiarization phase will occur 
on the second day, and the testing phase will occur on the third day. 
Memory will be measured as time spent exploring the novel object 
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over the familiar one. Rats with better memory will explore the novel 








The fear-conditioning test associates a conditional stimulus (CS) with 
an unconditional stimulus (US). The CS will be a light cue while the 
US will be a foot shock. When a foot shock is associated with a CS, 
rats will learn to fear that stimulus. Fear translates as freezing, or 
absence of movement.72 Fear conditioning will occur during week 7 of 
testing. The procedure will last 3 consecutive days total and will 
include a day of training (learning) and two days of testing (memory 
assessment).72 On the first day, rats will be presented both the CS and 
US. On the next two days, only the CS will be presented.72 Rats that 
have more freezing time are associated with better learning and 
memory since they are able to better remember the presence of a 
shock from training. 
 
 In week 8 of testing, electrophysiological recordings will be done in the hippocampal 
CA3-CA1 pathways. Rats will be anesthetized, and two holes will be drilled into their skulls for 
the stimulating and recording electrodes to enter.71 Excitatory postsynaptic potential (EPSPs) 
will be recorded at baseline rates. Then, high-frequency stimulation of 100 Hz will be used to 
induce an LTP response. Mean amplitudes will be calculated for pre-stimulation, basal EPSPs 
and high-frequency stimulated EPSPs.71   
After sacrifice (8 weeks), a variety of biomarkers will be tested. Apoptosis of 
hippocampal neurons and astrocytes will be analyzed using confocal microscopy. BDNF will be 
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measured by using in situ hybridization and enzyme-linked immunosorbent assay (ELISA).58 
Electron microscopy will be used to observe glutamergic synapse and postsynaptic density 
(PSD).58 Western blot will be used to analyze PSD proteins such as NMDAR, TrkB, and p75.  
Figure 11. Timeline for first experimental procedure 
 
Expected Outcomes  
It is predicted that the control group and probiotic-fed groups will perform better in the 
Barnes maze than the PTU-only group. It is likely that the control and probiotic-fed groups will 
have similar performances. In the object recognition test, the control group and probiotic-fed 
groups will spend more time near the novel object than the familiar object, while PTU-only rats 
will spend similar amounts of time near both objects. In the fear-conditioning test, the control 
group and probiotic-fed groups will have higher percentages of freezing time than the PTU-only 
group. In the electrophysiological tests of the hippocampus, it is predicted that basal rates will be 
similar in all groups. However, high-frequency stimulation will produce differences in LTPs. 
PTU-only rats will have significantly decreased potentiation compared to control and probiotic-
fed rats. Biomarkers for BDNF will be higher in PTU-only rats than in controls or probiotic-fed. 
In addition, NMDA and TrkB receptors will be lower in PTU-only rats than in other groups, and 
p75 will remain similar throughout all groups. PSD will be thinner in PTU-only rats than in other 
groups. Astrocyte and neuronal apoptosis will be significantly higher in PTU-only rats than in 
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other groups. It is important to note that rats in the PTU-probiotic are still lacking thyroid 
hormone. Thus, it is predicted that learning and memory behaviors, LTPs, and presence of 
certain biomarkers will be less than the control and probiotic-only groups. However, results for 
the PTU-probiotic group are projected to still be better than the PTU-only group. 
Observing the therapeutic effects of probiotics on depressive and anxiety symptoms in 
hypothyroidism 
In some hypothyroid patients who take L-thyroxine (T), reversal of anxiety and 
depressive symptoms is observed. However, there are also cases where mood symptoms persist 
even after thyroxine administration. Thus, a secondary treatment involving antidepressants 
and/or anxiolytics may be necessary to properly treat depression and anxiety symptoms in 
hypothyroid patients.4,77,78 The proposed clinical trial suggests use of a multi-strain 
Bifidobacteria probiotic mixture as treatment for depression and anxiety in place of typical 
antidepressant and anxiolytic drugs.  
Experimental Procedure:  
The following double-blind, randomized controlled clinical trial procedure is adapted 
from two trials done by Romijn et al and Steenbergen et al.69,70   
A total of 80 participants will be screened from adult (18+) hypothyroid patients with minor to 
severe depression and anxiety. Participants will have been taking L-thyroxine for at least 6 
months prior to the start of the experiment. Inclusion criteria will be as follows: (1) either ⩾11 
on the Quick Inventory of Depressive Symptomatology (QIDS-SR16) or ⩾14 on the depression 
subscale of the Depression, Anxiety and Stress Scale (DASS-42); (2) aged 18+ at the time of 
screening; and (3) free of any psychiatric medication for at least 4 weeks prior to the trial.70 
Demographics including sex, date of birth, ethnicity, household income, marital status, 
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occupation, and highest educational qualification will be obtained.70 Participants will not be able 
to take any antidepressants, anxiolytics, or other probiotic supplements during the trial. 
Additional exclusion criteria will be as follows: any neurological disorder, any serious medical 
condition that may require medical intervention during the trial, renal, hepatic, cardiovascular or 
respiratory disease, any pregnant or breastfeeding woman, serious suicide risk or risk of 
violence, use of any supplement with potentially antidepressant properties, any recent or current 
use of probiotics or antibiotics.70  
Scales for depression and anxiety will be administered as follows (Table 4): 
Table 4. Measurements for anxiety and depression 
 
 
Beck Anxiety Inventory 
This scale is a 21-item self-rating questionnaire for measuring 
severity of anxiety.79,80 Scores range from 0-63, with scores less than 
9 being normal and scores over 30 being very severe.69 Participants 
will be rated at baseline and every 2 weeks after for 8 weeks. 




The QIDS-SR16 is used to measure severity of depression.81,82 It is 
scored on a scale of 0-27, where a score less than 6 is rated as none 
and a score over 20 is rated as very severe.70 Participants will be 






Depression Rating Scale 
 
The MADRS is a questionnaire used to measure severity of 
depression on a 60-point scale, where a score higher than 35 is rated 
as severe and a score below 8 is rated as none. It contains 10 items 
and is broadly accepted for its sensitivity to change.83 Thus, it will be 
useful in measuring effects of treatment over the time of the trial.70 




This scale is a self-report questionnaire that contains 42 items. It is 
used to measure symptoms of depression, anxiety, and stress. 
Participants will be rated at baseline, at 4 weeks, and at 8 weeks.70  
 
The probiotic treatment will be administered in the form of sachets containing 2g of 
freeze-dried powder of a mixture containing the species Bifidobacterium longum, 
Bifidobacterium breve, and Bifidobacterium infantis (2.5 x 109 CFU/g).69   
The placebo sachets will contain 2g of freeze-dried powder containing maize starch and 
maltodextrins.69 It is imperative that the placebo has the same taste, color, and smell as the 
probiotic in order for the double-blind trial to be effective.  
The 80 participants will be randomly sorted into a placebo or probiotic group containing 
40 participants each. Participants will be given 4-weeks’ worth of treatment at a time. At 4 
weeks, participants will come to the lab for blood work, clinically-administered questionnaires, 
and to receive the last 4-weeks’ worth of treatment. They will be instructed to consume one 
sachet at the same time every day for 8-weeks by drinking the powder via water or milk. A 
reminder will be sent through text.69 
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Participants will be asked to log foods eaten, substances they drink (especially 
concerning caffeine and alcohol), and other habits that may affect results (nicotine or drug use). 
In addition, self-reports will be done every 2 weeks and participants will be asked to note any 
missed doses.70 
Biomarkers will be measured at baseline, 4 weeks, and 8 weeks. Blood samples and 
ELISA immunoassays will be used to measure levels of high-sensitivity C-reactive protein 
(hsCRP), IL-1β, IL-6, TNF-α, and BDNF. BDNF is involved in cognitive flexibility and hsCRP, 
IL-1β, IL-6, and TNF-α are biomarkers for inflammation.70,84 Urine testing for cortisol, a stress 
hormone, will be done.85 In addition, serum TSH levels will be measured at baseline, 4 weeks, 
and 8 weeks to ensure there is no significant variance.77 
Figure 12. Timeline for second experimental procedure 
 
Expected Outcomes  
It is predicted that participants administered the probiotic treatment will have lower 
scores on the depression/anxiety scales at 8 weeks compared to their baseline scores than those 
in the placebo group. Biomarkers for inflammation cortisol, and BDNF will be lower in the 
probiotic group than in the placebo. Serum TSH levels should remain the same for all 




CONCLUSIONS, LIMITATIONS, AND FUTURE AIMS 
Based on studies done previously in models of depression, anxiety, and cognition, it is 
anticipated that probiotic administration will help reduce cognitive and psychiatric symptoms, to 
antidepressants and other methods of treatment. 
Since previous studies have varied in their results, future research should attempt to 
observe probiotic effects on different species or strains of rats, as well as different methods of 
delivery. There is no certainty these probiotic strains will have the desired effects in humans if 
treatment is only successful in one strain of rats. Additionally, future research should explore 
different multi-species combinations or single strain administration as treatment. Both preclinical 
and clinical studies have produced varying results depending on the types of probiotics being 
administered. Some data suggests that multi-strain mixtures may be less efficient due to 
increased competition between species. Other data suggests that multi-strain mixtures are more 
efficient because of the larger concentration of bacteria present and a wider range of effects 
produced.86 This contradictory information should therefore be addressed in future work. 
Additionally, research involving administration of prebiotics alongside probiotics should be done 
to observe if beneficial effects of probiotics could be increased with prebiotics. Finally, the 
proposed studies could be repeated with additional groups being administered antidepressants. 
Thus, effects of antidepressants and probiotics in hypothyroid models could be studied alongside 
each other. Effects of combined administration of both antidepressants and probiotics could also 
be observed. 
Research in the field of probiotics is novel, and much is unknown as to how certain 
effects are produced by microbes via the gut-brain axis. Variations in results occur depending on 
strains of bacteria and rodents, making it difficult to translate successful preclinical results in 
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human models. As more researchers become attracted by the intriguing phenomena produced by 
probiotics, the field will greatly increase in knowledge. Until then, research should be done to 
increase knowledge of mechanisms involved in depression, anxiety, and memory, which will 
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